BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/17/2023 3:13:28 PM | Browse: 534 | Download: 1490
Publication Name World Journal of Orthopedics
Manuscript ID 81657
Country India
ISSN 2218-5836 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Critical Care Medicine
Manuscript Type Minireviews
Article Title Fungal arthritis: A challenging clinical entity
Manuscript Source Invited Manuscript
All Author List Anjali Mishra and Deven Juneja
ORCID
Author(s) ORCID Number
Anjali Mishra http://orcid.org/0000-0003-1492-3220
Deven Juneja http://orcid.org/0000-0002-8841-5678
Funding Agency and Grant Number
Corresponding Author Deven Juneja, Visiting Professor, Director, Director, Institute of Critical Care Medicine, Max Super Speciality Hospital, Saket, 1, Press Enclave Road, New Delhi 110017, India. devenjuneja@gmail.com
Key Words Aspergillus; Candida; Fungal arthritis; Invasive fungal infections; Osteomyelitis
Core Tip Fungal arthritis and osteomyelitis are rare diseases, but their incidence is increasing with the rising prevalence of predisposing factors. Most infections are secondary to Candida spp, especially Candida albicans, but patients rarely may develop infections secondary to other fungi, including Aspergillus, Histoplasma, cryptococcus and coccidioides. Fungal biomarkers may aid in rapid diagnosis in high-risk patients, but definitive diagnosis requires bone or synovial culture or biopsy. Surgical intervention and prolonged antifungal therapy form the mainstay of therapy, with azoles and echinocandins providing a safe and effective therapeutic option.
Publish Date 2023-02-17 15:13
Citation Mishra A, Juneja D. Fungal arthritis: A challenging clinical entity. World J Orthop 2023; 14(2): 55-63
URL https://www.wjgnet.com/2218-5836/full/v14/i2/55.htm
DOI https://dx.doi.org/10.5312/wjo.v14.i2.55
Full Article (PDF) WJO-14-55.pdf
Full Article (Word) WJO-14-55.docx